Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
Launched by COLUMBIA UNIVERSITY · Nov 19, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help people with spinal cord injuries, particularly those affecting the neck area, improve their ability to use their arms and hands. The researchers want to find out the best areas of the spinal cord to stimulate with electrical impulses, which might help activate the muscles needed for movement. This study is a preliminary step that will guide future trials aimed at making these treatments more effective.
To participate, individuals aged 65 to 74 who are recommended for cervical spine surgery may be eligible. However, those who already have stimulation devices in their neck or chest, like pacemakers, cannot take part. If someone joins the trial, they can expect to undergo short-term experiments that will help researchers understand how to best apply this new stimulation technique. Overall, this study aims to pave the way for better recovery options for individuals with cervical spinal cord injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • •Clinical indication for cervical spine surgery.
- Exclusion criteria:
- • •Stimulation devices in the neck or chest (e.g., vagal nerve stimulation, cardiac patients with pacemakers)
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
New York, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported